Arrowstreet Capital, Limited Partnership Gossamer Bio, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $120 Billion
- Q1 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 803,815 shares of GOSS stock, worth $844,005. This represents 0.0% of its overall portfolio holdings.
Number of Shares
803,815Holding current value
$844,005% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding GOSS
# of Institutions
127Shares Held
160MCall Options Held
2.11MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$19.3 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$19 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$10.6 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$8.46 Million7.27% of portfolio
-
Silverarc Capital Management, LLC6.32MShares$6.64 Million1.69% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $98.7M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...